About
CNS Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
184
By Phase
PHASE1/PHASE2: 1PHASE2/PHASE3: 1
By Status
ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT04875754Lead Sponsor
A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Mar 17, 2022 · Completed: Dec 31, 2026
NCT04382924Collaborator
Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease
PHASE2/PHASE3Completed
168 participants
Started: Aug 5, 2020 · Completed: Jan 26, 2021
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...